|
| CALPAIN NF1 |
|
https://doi.org/10.18632/oncotarget.25990
Ikrame Lazar, and Ze’ev A. Ronai
|
| 33051-33051 |
|
| CpG island hypermethylation go circular RNA |
|
https://doi.org/10.18632/oncotarget.26074
Mihnea P. Dragomir, and George A. Calin
|
| 33052-33053 |
|
| Checks and balances occur not only in government but also in biology |
|
https://doi.org/10.18632/oncotarget.25876
John T. Isaacs
|
| 33054-33055 |
|
| MACROD2 deletions cause impaired PARP1 activity and chromosome instability in colorectal cancer |
|
https://doi.org/10.18632/oncotarget.25887
Anuratha Sakthianandeswaren, Marie J. Parsons, Dmitri Mouradov, and Oliver M. Sieber
|
| 33056-33058 |
|
| 177LutetiumDotatate delays decline in quality of life in patients with midgut neuroendocrine tumors |
|
https://doi.org/10.18632/oncotarget.25942
Jonathan Strosberg
|
| 33059-33059 |
|
| Prognostic markers for colorectal cancer |
|
https://doi.org/10.18632/oncotarget.26012
Helen E.J. Tyrrell, and David Kerr
|
| 33060-33061 |
|
| Population based germline testing for primary cancer prevention |
|
https://doi.org/10.18632/oncotarget.25995
Ranjit Manchanda, and Rosa Legood
|
| 33062-33063 |
|
| mTORC1/2 inhibition resensitizes platinumresistant ovarian cancer by disrupting selective translation of DNA damage and survival mRNAs |
|
https://doi.org/10.18632/oncotarget.25869
Gizelka David-West, Amanda Ernlund, Abhilash Gadi, and Robert J. Schneider
|
| 33064-33076 |
|
| Distinct urinary glycoprotein signatures in prostate cancer patients |
|
https://doi.org/10.18632/oncotarget.26005
Rebeca Kawahara, Fabio Ortega, Livia Rosa-Fernandes, Vanessa Guimarães, Daniel Quina, Willian Nahas, Veit Schwämmle, Miguel Srougi, Katia R.M. Leite, Morten Thaysen-Andersen, Martin R. Larsen, and Giuseppe Palmisano
|
| 33077-33097 |
|
| Investigation of novel chemotherapeutics for feline oral squamous cell carcinoma |
|
https://doi.org/10.18632/oncotarget.26006
Hunter John Piegols, Marilia Takada, Maciej Parys, Thomas Dexheimer, and Vilma Yuzbasiyan-Gurkan
|
| 33098-33109 |
|
| The Jumonjidomain histone demethylase inhibitor JIB04 deregulates oncogenic programs and increases DNA damage in Ewing Sarcoma resulting in impaired cell proliferation and survival and reduced tumor growth |
|
https://doi.org/10.18632/oncotarget.26011
Janet K. Parrish, Tyler S. McCann, Marybeth Sechler, Lays M. Sobral, Wen Hua Ren, Kenneth L. Jones, Aik Choon Tan, and Paul Jedlicka
|
| 33110-33123 |
|
| Fludarabineresistance associates with ceramide metabolism and leukemia stem cell development in chronic lymphocytic leukemia |
|
https://doi.org/10.18632/oncotarget.26043
Chunfa Huang, Yifan Tu, and Carl E. Freter
|
| 33124-33137 |
|
| Trisenox disrupts MDM2DAXXHAUSP complex and activates p53 cell cycle regulation and apoptosis in acute leukemia cells |
|
https://doi.org/10.18632/oncotarget.26025
Sanjay Kumar, Andrea Brown, and Paul B. Tchounwou
|
| 33138-33148 |
|
| Comprehensive analysis identifying aberrant DNA methylation in rectal mucosa from ulcerative colitis patients with neoplasia |
|
https://doi.org/10.18632/oncotarget.26032
Yuji Toiyama, Yoshinaga Okugawa, Satoru Kondo, Yoshiki Okita, Toshimitsu Araki, Kurando Kusunoki, Motoi Uchino, Hiroki Ikeuchi, Seiichi Hirota, Akira Mitsui, Kenji Takehana, Tsutomu Umezawa, and Masato Kusunoki
|
| 33149-33159 |
|
| Prediction of nonmuscleinvasive bladder cancer recurrence by measurement of checkpoint HLAG’s receptor ILT2 on peripheral CD8+ T cells |
|
https://doi.org/10.18632/oncotarget.26036
Francois Desgrandchamps, Joel LeMaoult, Annabelle Goujon, Adrien Riviere, Antonio Rivero-Juarez, Malika Djouadou, Amory de Gouvello, Clement Dumont, Ching-Lien Wu, Stephane Culine, Jerome Verine, Nathalie Rouas-Freiss, Christophe Hennequin, Alexandra Masson-Lecomte, and Edgardo D. Carosella
|
| 33160-33169 |
|
| Autotaxinβ interaction with the cell surface via syndecan4 impacts on cancer cell proliferation and metastasis |
|
https://doi.org/10.18632/oncotarget.26039
Raphael Leblanc, Debashish Sahay, Audrey Houssin, Irma Machuca-Gayet, and Olivier Peyruchaud
|
| 33170-33185 |
|
| miR665 targets cMYC and HDAC8 to inhibit murine neuroblastoma cell growth |
|
https://doi.org/10.18632/oncotarget.26046
Nagindra Prashad
|
| 33186-33201 |
|
| Biochemical and cellular consequences of the antithrombin pMet1 mutation identified in a severe thrombophilic family |
|
https://doi.org/10.18632/oncotarget.26059
José Navarro-Fernández, MarÃa Eugenia de la Morena-Barrio, Emma MartÃnez-Alonso, Ingunn Dybedal, Mara Toderici, Nataliya Bohdan, Antonia Miñano, Ketil Heimdal, Ulrich Abildgaard, José Ãngel MartÃnez-Menárguez, Javier Corral, and Vicente Vicente
|
| 33202-33214 |
|
| Hematopoietic stem cell specific VATPase controls breast cancer progression and metastasis via cytotoxic T cells |
|
https://doi.org/10.18632/oncotarget.26061
Manoranjan Sahoo, Gajendra K. Katara, Mahmood Y. Bilal, Safaa A. Ibrahim, Arpita Kulshrestha, Sara Fleetwood, Kimiko Suzue, and Kenneth D. Beaman
|
| 33215-33231 |
|
| Prevalence of MDM2 amplification and coalterations in 523 advanced cancer patients in the MD Anderson phase 1 clinic |
|
https://doi.org/10.18632/oncotarget.26075
Vikas Dembla, Neeta Somaiah, Pedro Barata, Kenneth Hess, Siqing Fu, Filip Janku, Daniel D. Karp, Aung Naing, Sarina Anne Piha-Paul, Vivek Subbiah, Apostolia M. Tsimberidou, Kenna Shaw, Funda Meric-Bernstam, and David S. Hong
|
| 33232-33243 |
|
| Correction: Antibody targeting TSPAN12/βcatenin signaling in vasoproliferative retinopathy |
|
https://doi.org/10.18632/oncotarget.26102
Felicitas Bucher, Martin Friedlander, and Kyungmoo Yea
|
| 33244-33244 |
